Fig. 2
From: Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study
Percentage of women with fractures at treatment start and 10 years later for patients with osteoporosis treated with teriparatide, placebo and in women from the population sample, the WHO MONICA study, Gothenburg, Sweden. P-levels above the paired bars indicate within group comparison. The p-level with clambers indicates comparison between patients treated with teriparatide and the population sample, the WHO MONICA study, Gothenburg, at the 10-year follow-up